Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 409


Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer.

Woodward WA, Barlow WE, Jagsi R, Buchholz TA, Shak S, Baehner F, Whelan TJ, Davidson NE, Ingle JN, King TA, Ravdin PM, Osborne CK, Tripathy D, Livingston RB, Gralow JR, Hortobagyi GN, Hayes DF, Albain KS.

JAMA Oncol. 2020 Jan 9. doi: 10.1001/jamaoncol.2019.5559. [Epub ahead of print]


Excellent Locoregional Control in Inflammatory Breast Cancer With a Personalized Radiation Therapy Approach.

Stecklein SR, Rosso KJ, Nuanjing J, Tadros AB, Weiss A, DeSnyder SM, Kuerer HM, Teshome M, Buchholz TA, Stauder MC, Ueno NT, Lucci A, Woodward WA.

Pract Radiat Oncol. 2019 Nov;9(6):402-409. doi: 10.1016/j.prro.2019.05.011. Epub 2019 May 24.


Impact of Radiation on Locoregional Control in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Lymph Node Dissection: Results from ACOSOG Z1071 Clinical Trial.

Haffty BG, McCall LM, Ballman KV, Buchholz TA, Hunt KK, Boughey JC.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):174-182. doi: 10.1016/j.ijrobp.2019.04.038. Epub 2019 May 11.


Outcomes of Curative-Intent Treatment for Patients With Breast Cancer Presenting With Sternal or Mediastinal Involvement.

Christopherson K, Lei X, Barcenas C, Buchholz TA, Garg N, Hoffman KE, Kuerer HM, Mittendorf E, Perkins G, Shaitelman SF, Smith GL, Stauder M, Strom EA, Tereffe W, Woodward WA, Smith BD.

Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):574-581. doi: 10.1016/j.ijrobp.2019.02.049. Epub 2019 Mar 6.


James Daniel Cox, MD, FASTRO, FACR.

Wilson JF, Buchholz TA, Komaki R.

Int J Radiat Oncol Biol Phys. 2019 Mar 15;103(4):784-785. doi: 10.1016/j.ijrobp.2018.09.025. No abstract available. Erratum in: Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):470.


Optimizing Patient Positioning to Reduce Variation in the Measurement of Breast Cancer-Related Lymphedema.

DeSnyder SM, Kheirkhah P, Travis ML, Lilly SE, Bedrosian I, Buchholz TA, Schaverien MV, Shaitelman SF.

Lymphat Res Biol. 2019 Aug;17(4):440-446. doi: 10.1089/lrb.2018.0018. Epub 2018 Dec 18.


Accelerated partial breast irradiation: Current status with a focus on clinical practice.

Miranda FA, Teixeira LAB, Heinzen RN, de Andrade FEM, Hijal T, Buchholz TA, Moraes FY, Poortmans P, Marta GN.

Breast J. 2019 Jan;25(1):124-128. doi: 10.1111/tbj.13164. Epub 2018 Dec 7. Review.


Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update.

Burstein HJ, Lacchetti C, Anderson H, Buchholz TA, Davidson NE, Gelmon KA, Giordano SH, Hudis CA, Solky AJ, Stearns V, Winer EP, Griggs JJ.

J Clin Oncol. 2019 Feb 10;37(5):423-438. doi: 10.1200/JCO.18.01160. Epub 2018 Nov 19.


Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial.

Shaitelman SF, Lei X, Thompson A, Schlembach P, Bloom ES, Arzu IY, Buchholz D, Chronowski G, Dvorak T, Grade E, Hoffman K, Perkins G, Reed VK, Shah SJ, Stauder MC, Strom EA, Tereffe W, Woodward WA, Amaya DN, Shen Y, Hortobagyi GN, Hunt KK, Buchholz TA, Smith BD.

J Clin Oncol. 2018 Oct 31:JCO1800317. doi: 10.1200/JCO.18.00317. [Epub ahead of print]


A component of lobular carcinoma in clinically lymph node-negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer.

Van Wyhe RD, Caudle AS, Shaitelman SF, Perkins GH, Buchholz TA, Hoffman KE, Strom EA, Smith BD, Tereffe W, Woodward WA, Stauder MC.

Adv Radiat Oncol. 2018 Feb 26;3(3):252-257. doi: 10.1016/j.adro.2018.02.007. eCollection 2018 Jul-Sep.


Association of Transforming Growth Factor β Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Grossberg AJ, Lei X, Xu T, Shaitelman SF, Hoffman KE, Bloom ES, Stauder MC, Tereffe W, Schlembach PJ, Woodward WA, Buchholz TA, Smith BD.

JAMA Oncol. 2018 Dec 1;4(12):1751-1757. doi: 10.1001/jamaoncol.2018.2583.


Reply to: Mastectomy skin flap thickness.

Marta GN, Poortmans P, de Barros AC, Filassi JR, Freitas-Junior R, Audisio RA, Mano MS, Meterissian S, DeSnyder SM, Buchholz TA, Hijal T.

Eur J Surg Oncol. 2018 Jul;44(7):1119-1120. doi: 10.1016/j.ejso.2018.04.009. Epub 2018 Apr 27. No abstract available.


The role of postmastectomy radiotherapy in patients with stage II breast cancer.

Ohri N, Haffty BG, Buchholz TA.

Cancer. 2018 Feb 1;124(3):450-452. doi: 10.1002/cncr.31130. Epub 2017 Dec 12. No abstract available.


Use of regional nodal irradiation and its association with survival for women with high-risk, early stage breast cancer: A National Cancer Database analysis.

Moreno AC, Lin YH, Bedrosian I, Shen Y, Stauder MC, Smith BD, Buchholz TA, Babiera GV, Woodward WA, Shaitelman SF.

Adv Radiat Oncol. 2017 May 3;2(3):291-300. doi: 10.1016/j.adro.2017.04.008. eCollection 2017 Jul-Sep.


Using Discrete-Event Simulation to Promote Quality Improvement and Efficiency in a Radiation Oncology Treatment Center.

Famiglietti RM, Norboge EC, Boving V, Langabeer JR 2nd, Buchholz TA, Mikhail O.

Qual Manag Health Care. 2017 Oct/Dec;26(4):184-189. doi: 10.1097/QMH.0000000000000145.


Multidisciplinary international survey of post-operative radiation therapy practices after nipple-sparing or skin-sparing mastectomy.

Marta GN, Poortmans P, de Barros AC, Filassi JR, Freitas Junior R, Audisio RA, Mano MS, Meterissian S, DeSnyder SM, Buchholz TA, Hijal T.

Eur J Surg Oncol. 2017 Nov;43(11):2036-2043. doi: 10.1016/j.ejso.2017.09.014. Epub 2017 Sep 19.


A phase 2 study of capecitabine and concomitant radiation in women with advanced breast cancer.

Woodward WA, Fang P, Arriaga L, Gao H, Cohen EN, Reuben JM, Valero V, Le-Petross H, Middleton LP, Babiera GV, Strom EA, Tereffe W, Hoffman K, Smith BD, Buchholz TA, Perkins GH.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):777-783. doi: 10.1016/j.ijrobp.2017.04.030. Epub 2017 May 3. Erratum in: Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):497.


A clinical perspective on regional nodal irradiation for breast cancer.

Moreno AC, Shaitelman SF, Buchholz TA.

Breast. 2017 Aug;34 Suppl 1:S85-S90. doi: 10.1016/j.breast.2017.06.035. Epub 2017 Jul 8. Review.


Quantitative Assessment of Breast Cosmetic Outcome After Whole-Breast Irradiation.

Reddy JP, Lei X, Huang SC, Nicklaus KM, Fingeret MC, Shaitelman SF, Hunt KK, Buchholz TA, Merchant F, Markey MK, Smith BD.

Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):894-902. doi: 10.1016/j.ijrobp.2016.12.021. Epub 2016 Dec 21.


Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype.

Symmans WF, Wei C, Gould R, Yu X, Zhang Y, Liu M, Walls A, Bousamra A, Ramineni M, Sinn B, Hunt K, Buchholz TA, Valero V, Buzdar AU, Yang W, Brewster AM, Moulder S, Pusztai L, Hatzis C, Hortobagyi GN.

J Clin Oncol. 2017 Apr 1;35(10):1049-1060. doi: 10.1200/JCO.2015.63.1010. Epub 2017 Jan 30.


MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells.

Bridges KA, Chen X, Liu H, Rock C, Buchholz TA, Shumway SD, Skinner HD, Meyn RE.

Oncotarget. 2016 Nov 1;7(44):71660-71672. doi: 10.18632/oncotarget.12311.


Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells.

Ilmer M, Mazurek N, Gilcrease MZ, Byrd JC, Woodward WA, Buchholz TA, Acklin K, Ramirez K, Hafley M, Alt E, Vykoukal J, Bresalier RS.

Breast Cancer Res. 2016 Sep 29;18(1):97. doi: 10.1186/s13058-016-0757-6.


Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy.

Stauder MC, Caudle AS, Allen PK, Shaitelman SF, Smith BD, Hoffman KE, Buchholz TA, Chavez-Macgregor M, Hunt KK, Meric-Bernstam F, Woodward WA.

Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):637-44. doi: 10.1016/j.ijrobp.2016.07.003. Epub 2016 Jul 13.


Cost and Complications of Local Therapies for Early-Stage Breast Cancer.

Smith BD, Jiang J, Shih YC, Giordano SH, Huo J, Jagsi R, Momoh AO, Caudle AS, Hunt KK, Shaitelman SF, Buchholz TA, Shirvani SM.

J Natl Cancer Inst. 2016 Sep 27;109(1). doi: 10.1093/jnci/djw178. Print 2017 Jan. Erratum in: J Natl Cancer Inst. 2018 Oct 1;110(10):1148-1152.


Postoperative Radiation Therapy after Nipple-Sparing or Skin-Sparing Mastectomy: A Survey of European, North American, and South American Practices.

Marta GN, Poortmans PM, Buchholz TA, Hijal T.

Breast J. 2017 Jan;23(1):26-33. doi: 10.1111/tbj.12683. Epub 2016 Sep 9.


TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects.

Wang L, Zhang P, Molkentine DP, Chen C, Molkentine JM, Piao H, Raju U, Zhang J, Valdecanas DR, Tailor RC, Thames HD, Buchholz TA, Chen J, Ma L, Mason KA, Ang KK, Meyn RE, Skinner HD.

Oncogene. 2017 Feb 9;36(6):820-828. doi: 10.1038/onc.2016.250. Epub 2016 Jul 18.


Longitudinal analysis of patient-reported outcomes and cosmesis in a randomized trial of conventionally fractionated versus hypofractionated whole-breast irradiation.

Swanick CW, Lei X, Shaitelman SF, Schlembach PJ, Bloom ES, Fingeret MC, Strom EA, Tereffe W, Woodward WA, Stauder MC, Dvorak T, Thompson AM, Buchholz TA, Smith BD.

Cancer. 2016 Sep 15;122(18):2886-94. doi: 10.1002/cncr.30121. Epub 2016 Jun 15.


Supply and Demand for Radiation Oncology in the United States: Updated Projections for 2015 to 2025.

Pan HY, Haffty BG, Falit BP, Buchholz TA, Wilson LD, Hahn SM, Smith BD.

Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):493-500. doi: 10.1016/j.ijrobp.2016.02.064. Epub 2016 Mar 5.


Postmastectomy Radiation Treatment Rates as a Quality Measure: An Opportunity for Compliance Through Collaboration.

Fayanju OM, Buchholz TA, Hunt KK.

Ann Surg Oncol. 2016 Aug;23(8):2377-9. doi: 10.1245/s10434-016-5258-4. Epub 2016 May 9. No abstract available.


miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer.

Debeb BG, Lacerda L, Anfossi S, Diagaradjane P, Chu K, Bambhroliya A, Huo L, Wei C, Larson RA, Wolfe AR, Xu W, Smith DL, Li L, Ivan C, Allen PK, Wu W, Calin GA, Krishnamurthy S, Zhang XH, Buchholz TA, Ueno NT, Reuben JM, Woodward WA.

J Natl Cancer Inst. 2016 Apr 13;108(8). doi: 10.1093/jnci/djw026. Print 2016 Aug.


Trends in Local Therapy Utilization and Cost for Early-Stage Breast Cancer in Older Women: Implications for Payment and Policy Reform.

Shirvani SM, Jiang J, Likhacheva A, Hoffman KE, Shaitelman SF, Caudle A, Buchholz TA, Giordano SH, Smith BD.

Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):605-16. doi: 10.1016/j.ijrobp.2016.01.059. Epub 2016 Feb 6.


Value-Based Breast Cancer Care: A Multidisciplinary Approach for Defining Patient-Centered Outcomes.

Fayanju OM, Mayo TL, Spinks TE, Lee S, Barcenas CH, Smith BD, Giordano SH, Hwang RF, Ehlers RA, Selber JC, Walters R, Tripathy D, Hunt KK, Buchholz TA, Feeley TW, Kuerer HM.

Ann Surg Oncol. 2016 Aug;23(8):2385-90. doi: 10.1245/s10434-016-5184-5. Epub 2016 Mar 15.


Variations in Proton Therapy Coverage in the State of Texas: Defining Medical Necessity for a Safe and Effective Treatment.

Thaker NG, Agarwal A, Palmer M, Hontiveros R, Hahn SM, Minsky BD, Walters R, Bingham J, Feeley TW, Buchholz TA, Frank SJ.

Int J Part Ther. 2016 Mar;2(4):499-508. doi: 10.14338/IJPT-15-00029.1. Epub 2016 Mar 24.


Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing.

Thaker NG, Pugh TJ, Mahmood U, Choi S, Spinks TE, Martin NE, Sio TT, Kudchadker RJ, Kaplan RS, Kuban DA, Swanson DA, Orio PF, Zelefsky MJ, Cox BW, Potters L, Buchholz TA, Feeley TW, Frank SJ.

Brachytherapy. 2016 May-Jun;15(3):274-282. doi: 10.1016/j.brachy.2016.01.003. Epub 2016 Feb 23.


Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression.

Burstein HJ, Lacchetti C, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, Giordano SH, Hudis CA, Solky AJ, Stearns V, Winer EP, Griggs JJ.

J Clin Oncol. 2016 May 10;34(14):1689-701. doi: 10.1200/JCO.2015.65.9573. Epub 2016 Feb 16. Review.


Patterns of Local-Regional Management Following Neoadjuvant Chemotherapy in Breast Cancer: Results From ACOSOG Z1071 (Alliance).

Haffty BG, McCall LM, Ballman KV, McLaughlin S, Jagsi R, Ollila DW, Hunt KK, Buchholz TA, Boughey JC.

Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):493-502. doi: 10.1016/j.ijrobp.2015.11.005. Epub 2015 Nov 10.


Practical Implications of the Publication of Consensus Guidelines by the American Society for Radiation Oncology: Accelerated Partial Breast Irradiation and the National Cancer Data Base.

Shaitelman SF, Lin HY, Smith BD, Shen Y, Bedrosian I, Marsh GD, Bloom ES, Vicini FA, Buchholz TA, Babiera GV.

Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):338-48. doi: 10.1016/j.ijrobp.2015.10.059. Epub 2015 Oct 31.


Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy.

Mougalian SS, Hernandez M, Lei X, Lynch S, Kuerer HM, Symmans WF, Theriault RL, Fornage BD, Hsu L, Buchholz TA, Sahin AA, Hunt KK, Yang WT, Hortobagyi GN, Valero V.

JAMA Oncol. 2016 Apr;2(4):508-16. doi: 10.1001/jamaoncol.2015.4935.


Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.

Lin SH, Zhang N, Godby J, Wang J, Marsh GD, Liao Z, Komaki R, Ho L, Hofstetter WL, Swisher SG, Mehran RJ, Buchholz TA, Elting LS, Giordano SH.

Cancer. 2016 Mar 15;122(6):917-28. doi: 10.1002/cncr.29857. Epub 2015 Dec 30.


Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy.

Reddy JP, Dawood S, Mitchell M, Debeb BG, Bloom E, Gonzalez-Angulo AM, Sulman EP, Buchholz TA, Woodward WA.

Radiother Oncol. 2015 Nov;117(2):308-14. doi: 10.1016/j.radonc.2015.10.009. Epub 2015 Oct 16.


Sonography and Sonographically Guided Needle Biopsy of Internal Mammary Nodes in Staging of Patients With Breast Cancer.

Dogan BE, Dryden MJ, Wei W, Fornage BD, Buchholz TA, Smith B, Hunt K, Krishnamurthy S, Yang WT.

AJR Am J Roentgenol. 2015 Oct;205(4):905-11. doi: 10.2214/AJR.15.14307.


Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy.

Bishop AJ, Ensor J, Moulder SL, Shaitelman SF, Edson MA, Whitman GJ, Bishnoi S, Hoffman KE, Stauder MC, Valero V, Buchholz TA, Ueno NT, Babiera G, Woodward WA.

Cancer. 2015 Dec 15;121(24):4324-32. doi: 10.1002/cncr.29681. Epub 2015 Sep 8.


Role of Ultrasonography of Regional Nodal Basins in Staging Triple-Negative Breast Cancer and Implications For Local-Regional Treatment.

Shaitelman SF, Tereffe W, Dogan BE, Hess KR, Caudle AS, Valero V, Stauder MC, Krishnamurthy S, Candelaria RP, Strom EA, Woodward WA, Hunt KK, Buchholz TA, Whitman GJ.

Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):102-10. doi: 10.1016/j.ijrobp.2015.05.015. Epub 2015 May 16.


Utilization and Outcomes of Breast Brachytherapy in Younger Women.

Smith GL, Huo J, Giordano SH, Hunt KK, Buchholz TA, Smith BD.

Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):91-101. doi: 10.1016/j.ijrobp.2015.05.010. Epub 2015 May 14.


Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.

Shaitelman SF, Schlembach PJ, Arzu I, Ballo M, Bloom ES, Buchholz D, Chronowski GM, Dvorak T, Grade E, Hoffman KE, Kelly P, Ludwig M, Perkins GH, Reed V, Shah S, Stauder MC, Strom EA, Tereffe W, Woodward WA, Ensor J, Baumann D, Thompson AM, Amaya D, Davis T, Guerra W, Hamblin L, Hortobagyi G, Hunt KK, Buchholz TA, Smith BD.

JAMA Oncol. 2015 Oct;1(7):931-41. doi: 10.1001/jamaoncol.2015.2666.


Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults.

Smith BD, Jiang J, Chang JY, Welsh J, Likhacheva A, Buchholz TA, Swisher SG, Shirvani SM.

J Geriatr Oncol. 2015 Jul;6(4):324-31. doi: 10.1016/j.jgo.2015.05.002. Epub 2015 Jun 17.


Erratum to: Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.

Fouad TM, Kogawa T, Liu DD, Shen Y, Masuda H, El-Zein R, Woodward WA, Chavez-MacGregor M, Alvarez RH, Arun B, Lucci A, Krishnamurthy S, Babiera G, Buchholz TA, Valero V, Ueno NT.

Breast Cancer Res Treat. 2015 Jul;152(2):417. doi: 10.1007/s10549-015-3477-1. No abstract available.


Surgical Considerations After Neoadjuvant Chemotherapy: Breast Conservation Therapy.

Buchholz TA, Mittendorf EA, Hunt KK.

J Natl Cancer Inst Monogr. 2015 May;2015(51):11-4. doi: 10.1093/jncimonographs/lgv020.


Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.

Fouad TM, Kogawa T, Liu DD, Shen Y, Masuda H, El-Zein R, Woodward WA, Chavez-MacGregor M, Alvarez RH, Arun B, Lucci A, Krishnamurthy S, Babiera G, Buchholz TA, Valero V, Ueno NT.

Breast Cancer Res Treat. 2015 Jul;152(2):407-16. doi: 10.1007/s10549-015-3436-x. Epub 2015 May 29. Erratum in: Breast Cancer Res Treat. 2015 Jul;152(2):417.


Time to treatment as a quality metric in lung cancer: Staging studies, time to treatment, and patient survival.

Gomez DR, Liao KP, Swisher SG, Blumenschein GR, Erasmus JJ Jr, Buchholz TA, Giordano SH, Smith BD.

Radiother Oncol. 2015 May;115(2):257-63. doi: 10.1016/j.radonc.2015.04.010. Epub 2015 May 23.


Supplemental Content

Loading ...
Support Center